Asian Spectator

Men's Weekly

.

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Powering Seamless Internet for Exhibitions, Conferences, and Live Events

In Singapore’s MICE (Meetings, Incentives, Conferences, and Exhibitions) industry, expectations for flawless execution are matched by a demand for flawless connectivity. Whether it’s a high-stakes t...

Di tengah dunia yang ‘sepi’, maraknya ‘teman AI’ bawa risiko mental bahkan nyawa

Cheng Xin/Getty Images NewsPERINGATAN: Artikel ini memuat konten yang berkaitan dengan bunuh diri, melukai diri sendiri, dan kekerasan terhadap orang lain.Hanya dua hari setelah merilis teman AI bulan...

Understanding the Divorce Process: A Step-by-Step Guide for Families

Divorce can feel overwhelming, especially when emotions run high and the future seems uncertain. During these struggles, many people seek help from family lawyers, but having a working understanding...